Olivier Litzka

Olivier Litzka currently works at Medlumics SL, as Vice Chairman from 2021, JenaValve Technology GmbH, as Director from 2013, T-Knife GmbH, as Director, HighLife SAS, as Director, Ariceum Therapeutics GmbH, as Non-Executive Director, JenaValve Technology, Inc., as Director, Andera Partners SCA, as Partner from 2018, and TME Pharma AG, as Member-Supervisory Board.
Dr. Litzka also formerly worked at Sapiens Steering Brain Stimulation BV, as Director, Sapiens Steering Brain Stimulation GmbH, as Director, Allecra Therapeutics GmbH, as Director, Parvulus Medical SAS, as Executive Director, Arvelle Therapeutics International GmbH, as Director, Autonomic Technologies, Inc., as Director, Novexel SA, as Director, ENDOSENSE SA, as Director-Executive Board from 2010 to 2013, Mineralys Therapeutics, Inc., as Independent Director from 2022 to 2024, TME Pharma NV, as Member-Supervisory Board, Vivoryon Therapeutics NV, as Member-Supervisory Board from 2009 to 2016, and SuperSonic Imagine SA, as Member-Supervisory Board.
Dr. Litzka received his doctorate degree from Institut Für Medizinische Mikrobiologie.